Ms. Jenn Hepburn reports
EMERALD HEALTH THERAPEUTICS ANNOUNCES PURE SUNFARMS INITIAL CULTIVATION AND SALES LICENSE FOR SECOND GREENHOUSE
Emerald Health Therapeutics Inc.'s joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area within its second 1.1-million-square-foot greenhouse facility in Delta, B.C. (the Delta 2 facility), allowing it to expand capacity as needed through successive licence amendments. The Delta 2 facility is adjacent to its established, fully operating 1.1-million-square-foot Delta 3 greenhouse facility and, when in production, is expected to contribute to further lowering Pure Sunfarms' already industry-leading cost of cultivation.
On the heels of the leading market share performance of its British Columbia-grown dried cannabis products (1), Pure Sunfarms is now preparing to roll out its first bottled cannabis oils and cannabis 2.0 offerings this summer. Pure Sunfarms' cannabis 2.0 rollout will begin with a selection of prefilled 510 vape cartridges, available in the extract forms of its top-selling (1) dried cannabis strains, as well as a selection of disposable vape pens -- all under the highly regarded and well trusted Pure Sunfarms brand.
"The ongoing expansion of Pure Sunfarms' cultivation capacity and extension of its product lines will continue to expand its flexibility and competitiveness to offer consumers choices that meet their preferences in form, quality and value -- which are already being met as seen through Pure Sunfarms' stellar performance, for example, in Ontario (1)," said Riaz Bandali, president and chief executive officer of Emerald. "We expect Pure Sunfarms to continue to build on its operating and market leadership in its broad segment of the market."
(1) Market share performance is based on calculations by Pure Sunfarms from sales information provided by the Ontario Cannabis Store.
About Emerald Health Therapeutics Inc.
Emerald Health Therapeutics is committed to cutting-edge cannabis science to create new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products. With an emphasis on innovation and production excellence, Emerald's three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.